{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:24:43Z","timestamp":1773840283973,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Cutaneous leishmaniasis, caused by protozoan parasites of the\n                    <jats:italic>Leishmania<\/jats:italic>\n                    genus, remains a significant health concern in endemic regions such as the Middle-East, Asia, Latin America, and North Africa. The disease affects millions of people worldwide, with over one million new infections reported annually. Despite its health impact, there is currently no approved vaccine largely due to limited understanding of immunological mechanisms underlying protective immunity and disease pathogenesis. We previously reported that long pentraxin 3 (PTX3), a pattern recognition molecule involved in inflammation, tissue repair, and wound healing, is a negative regulator of immunity in primary\n                    <jats:italic>Leishmania major<\/jats:italic>\n                    infection. Specifically, we showed that PTX3 exacerbates disease by suppressing protective Th17 responses. Here, we extend these findings by showing that PTX3 also influences secondary (memory) immunity to\n                    <jats:italic>L. major<\/jats:italic>\n                    .\n                    <jats:italic>PTX3<\/jats:italic>\n                    -deficient (\n                    <jats:italic>PTX3<\/jats:italic>\n                    <jats:sup>-\/-<\/jats:sup>\n                    ) mice which had resolved a primary infection exhibited enhanced resistance to secondary challenge compared to their wild-type (WT) controls. This enhanced resistance correlated with higher frequencies of effector memory CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in the spleens and draining lymph nodes. Upon re-infection, healed\n                    <jats:italic>\n                      PTX3\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    mice produced significantly more IL-17A, while levels of IFN-\u03b3, TNF-\u03b1, and IL-10 were similar.\n                    <jats:italic>In vivo<\/jats:italic>\n                    BrdU incorporation assays further revealed increased proliferation of IL-17\n                    <jats:sup>+<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in\n                    <jats:italic>\n                      PTX3\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    mice. Importantly, neutralization of IL-17A during secondary challenge abolished the enhanced resistance observed in\n                    <jats:italic>\n                      PTX3\n                      <jats:sup>-\/-<\/jats:sup>\n                    <\/jats:italic>\n                    mice, confirming a central role of IL-17 in PTX3-regulated secondary immunity. Collectively, our findings identify PTX3 as a key regulator of secondary immunity in cutaneous leishmaniasis and underscores the importance of IL-17 in this process.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1740323","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:51:49Z","timestamp":1770706309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long pentraxin 3 (PTX3) regulates IL-17A-mediated secondary immunity to Leishmania major infection in mice"],"prefix":"10.3389","volume":"17","author":[{"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Mou","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwunonso","family":"Onyilagha","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianyu","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelilah","family":"Soussi-Gounni","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude E.","family":"Uzonna","sequence":"additional","affiliation":[{"name":"Department of Immunology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]},{"name":"Department of Medical Microbiology & Infectious Diseases, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]},{"name":"Department of Pathology, Max Rady College of Medicine, University of Manitoba","place":["Winnipeg, MB, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2019.01.002","article-title":"Cutaneous leishmaniasis: A neglected disfiguring disease for women","volume":"5","author":"Bilgic-Temel","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0007092","DOI":"10.1371\/journal.pntd.0007092","article-title":"Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates","volume":"13","author":"Bailey","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20210238","article-title":"Cutaneous leishmaniasis in travellers and migrants: a 10-year case series in a Canadian reference centre for tropical diseases","volume":"10","author":"Lemieux","year":"2022","journal-title":"CMAJ Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905184106","article-title":"Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process","volume":"106","author":"Okwor","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum Vaccin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708535200","article-title":"Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization","volume":"283","author":"Inforzato","year":"2008","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1274634","article-title":"Structural insights into the biological functions of the long pentraxin PTX3","volume":"14","author":"Massimino","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00712","article-title":"The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer","volume":"10","author":"Doni","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.tim.2015.09.006","article-title":"Pentraxins and collectins: friend or foe during pathogen invasion","volume":"23","author":"Foo","year":"2015","journal-title":"Trends Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12476","article-title":"Pentraxins in the activation and regulation of innate immunity","volume":"274","author":"Daigo","year":"2016","journal-title":"Immunol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"108513","DOI":"10.1016\/j.celrep.2020.108513","article-title":"The long pentraxin 3 (PTX3) suppresses immunity to cutaneous leishmaniasis by regulating CD4","volume":"33","author":"Gupta","year":"2020","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343477","article-title":"STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis","volume":"44","author":"Oghumu","year":"2014","journal-title":"Eur J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202537","article-title":"Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion","volume":"190","author":"Mou","year":"2013","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0007708","DOI":"10.1371\/journal.pntd.0007708","article-title":"Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression","volume":"13","author":"Bosch-Nicolau","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8449","DOI":"10.1038\/s41467-023-44297-6","article-title":"Antigen recognition reinforces regulatory T cell mediated Leishmania major persistence","volume":"14","author":"Zayats","year":"2023","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040298","article-title":"Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity","volume":"200","author":"Mendez","year":"2004","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830221206","article-title":"Role of T cell subsets during the recall of immunologic memory to Leishmania major","volume":"22","author":"M\u00fcller","year":"1992","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.9.3730-3738.1993","article-title":"Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells","volume":"61","author":"M\u00fcller","year":"1993","journal-title":"Infect Immun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae251","article-title":"IL-17A\/IFN-\u03b3 producing \u03b3\u03b4 T cell functional dichotomy impacts cutaneous leishmaniasis in mice","volume":"117","author":"Dos-Santos","year":"2025","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1009693","DOI":"10.1371\/journal.ppat.1009693","article-title":"Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis","volume":"17","author":"Singh","year":"2021","journal-title":"PloS Pathog"},{"key":"B26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","article-title":"Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection","volume":"27","author":"Kaech","year":"2007","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/1573395509666131126231209","article-title":"Early decision: effector and effector memory T cell differentiation in chronic infection","volume":"9","author":"Opata","year":"2013","journal-title":"Curr Immunol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.007","article-title":"Diversity in T cell memory: an embarrassment of riches","volume":"31","author":"Jameson","year":"2009","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1058867","article-title":"Preferential localization of effector memory cells in nonlymphoid tissue","volume":"291","author":"Masopust","year":"2001","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01727.x","article-title":"Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues","volume":"110","author":"Bjorkdahl","year":"2003","journal-title":"Immunology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308054101","article-title":"Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets","volume":"101","author":"Huster","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/35065111","article-title":"Visualizing the generation of memory CD4 T cells in the whole body","volume":"410","author":"Reinhardt","year":"2001","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu531","article-title":"Interleukin 17A acts synergistically with interferon \u03b3 to promote protection against Leishmania infantum infection","volume":"211","author":"Nascimento","year":"2015","journal-title":"J Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38813","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1003243","DOI":"10.1371\/journal.ppat.1003243","article-title":"IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection","volume":"9","author":"Gonzalez-Lombana","year":"2013","journal-title":"PloS Pathog"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002035","article-title":"The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa","volume":"186","author":"Moalli","year":"2011","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae: going on the offense with a strong defense","volume":"80","author":"Paczosa","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666198","article-title":"The long pentraxin PTX3 controls","volume":"12","author":"Asgari","year":"2021","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.12.017","article-title":"Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice","volume":"8","author":"Soares","year":"2006","journal-title":"Microbes Infect"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000180265","article-title":"Sex hormones and modulation of immunity against leishmaniasis","volume":"16","author":"Snider","year":"2009","journal-title":"Neuroimmunomodulation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02808","article-title":"The influence of pentraxin 3 on the ovarian function and its impact on fertility","volume":"9","author":"Camaioni","year":"2018","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1817792","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1740323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:40:05Z","timestamp":1773826805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1740323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2026.1740323"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1740323","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1740323"}}